ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,813,000 | -76.8% | 39,589 | -83.1% | 0.40% | -76.2% |
Q2 2021 | $29,319,000 | +21.1% | 233,638 | +30.9% | 1.69% | +16.1% |
Q1 2021 | $24,212,000 | +415.8% | 178,538 | +386.6% | 1.46% | +421.9% |
Q4 2020 | $4,694,000 | -29.9% | 36,688 | -38.4% | 0.28% | -43.9% |
Q3 2020 | $6,700,000 | -67.6% | 59,546 | -72.6% | 0.50% | -61.9% |
Q2 2020 | $20,710,000 | +39.5% | 217,390 | +31.6% | 1.31% | -4.9% |
Q1 2020 | $14,843,000 | +90.4% | 165,160 | +12.3% | 1.37% | +144.3% |
Q4 2019 | $7,796,000 | -51.7% | 147,032 | -64.0% | 0.56% | -61.5% |
Q3 2019 | $16,130,000 | +62.9% | 408,262 | +69.4% | 1.46% | +60.2% |
Q2 2019 | $9,902,000 | – | 241,043 | – | 0.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |